Chapter 6.1.2. Diffuse Lung Disease

Evidence-based Approach to Treatment of Sarcoidosis

  1. Peter G. Gibson1,
  2. Michael Abramson2,
  3. Richard Wood-Baker3,
  4. Jimmy Volmink4,
  5. Michael Hensley5,
  6. Ulrich Costabel6
  1. Robert P Baughman,
  2. Olof Selroos

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987377.ch37

Evidence-based Respiratory Medicine

Evidence-based Respiratory Medicine

How to Cite

Baughman, R. P. and Selroos, O. (2007) Diffuse Lung Disease, in Evidence-based Respiratory Medicine (eds P. G. Gibson, M. Abramson, R. Wood-Baker, J. Volmink, M. Hensley and U. Costabel), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987377.ch37

Editor Information

  1. 1

    John Hunter Hospital, Newcastle, New South Wales, Australia

  2. 2

    Monash University, Central & Eastern Clinical School, The Alfred, Melbourne, Victoria, Australia

  3. 3

    University of Tasmania, Hobart, Tasmania, Australia

  4. 4

    University of Cape Town, Cape Town, South Africa

  5. 5

    University of Newcastle, Newcastle, New South Wales, Australia

  6. 6

    Ruhrlandklinik, Essen, Germany

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 22 NOV 2005

ISBN Information

Print ISBN: 9780727916051

Online ISBN: 9780470987377

SEARCH

Keywords:

  • sarcoidosis;
  • corticosteroid therapy;
  • pulmonary sarcoidosis;
  • oral corticosteroids;
  • inhaled corticosteroids

Summary

This chapter contains sections titled:

  • Level of evidence to support a recommendation

  • Corticosteroid therapy

  • Pulmonary sarcoidosis

  • Chronic pulmonary sarcoidosis on treatment with systemic corticosteroids

  • Extrapulmonary sarcoidosis

  • Alternatives to corticosteroids

  • Specific agents